likelihood of having obstruction MAG3 findings .On the other hand, an APD of greater than 15 cm had 9.2 times (95 % CI 3.01-28.57) higher likelihood of having obstruction MAG 3 findings. MAG 3 showed that 68 (30%) patients had full clearance of tracer; 71 (31,5 %) patients had clearance more than 50%; 27 (12%) patients had a clearance less than 50%; and 59 (26.2%) patients had an obstructive pattern. The mean AP diameters were 29.76 15.8mm, 23.46 10.6 mm, 15.1 6 7.5mm, 13.66 4.6 mm, in patients with obstruction, low excretion, high excretion, and normal excretion, respectively.The incidence of urinary tract infections was lower than in the obstructive group than the other groups . The number of patients with a DRF of greater than 40 was relatively lower but substantial. The regression analysis showed that an APD of smaller than 20mm was a risk factor for obstruction (OR ¼0.145 and 95% CI ¼0.04-0.47, OR ¼0.063 and 95% CI ¼0.02-0.17, respectively). However, the regression analysis showed that an APD of greater than 15 mm was not a risk factor for obstruction and low DRF. CONCLUSIONS: The combination of ultrasound and MAG 3 provides the necessary anatomical and functional information to follow the degree of obstruction and to decide between surgical intervention and conservative follow-up. Our study supports a threshold of 20 mm rather than 15 mm for severe obstruction. However, neither 15 nor 20 mm had a predictive value in DRF estimation.
INTRODUCTION AND AIMS:
Determination of diagnostic values of cystatin C serum concentration in combination with the estimated glomerular filtration rate (eGFR) gives clinicians an advantage in clearly delineating the stages of chronic kidney disease (CKD) in children. The aim of the study was to determine the diagnostic values of Cystatin C serum concentration with the eGFR for the differentiation of CKD I-III stages in children. METHODS: In 119 children aged 2 to 17 years (7.3 6 0.3 years), diagnostic values of Cystatin C serum levels were determined to clarify CKD I-III stages, eGFR based on the serum concentration of cystatin C, using the equations: F. J. Hoek, M. Zappitelli, Pediatric GFR Calculator-NKF. RESULTS: In children with CKD I stage serum concentration of cystatin C was 0.77 6 0.01 mg / l, which is significantly lower than the corresponding values in patients with CKD II stage (1,0 6 0,01 mg / l) and III stage (1.58 6 0.06 mg / l) (p <0.05). The mean value of the concentration of cystatin C in the blood serum was 0.77 6 0.01 mg / l in patients with CKD corresponded to the eGFR on the basis of cystatin C 100.2 6 1.6 ml / min / 1.73 m 2 , determined according to the equation F.J.Hoek, 103.6 6 1.9 ml / min / 1.73 m 2 -according to the equation M. Zappitelli and 90.4 6 1.3 mL / min / 1.73 m 2 by the Pediatric GFR Calculator-NKF. The average value of the concentration of cystatin C in the blood serum was 1.0 6 0.01 mg / l in patients with CKD of the II stage corresponded to the eGFR on the basis of cystatin C 77.5 6 0.87 ml / min / 1.73 m 2 according to the equation F.J.Hoek, 77.6 6 0.97 ml / min / 1.73 m 2 -according to the equation M. Zappitelli and 71 , 9 6 0.7 ml / min / 1.73m 2 by the Pediatric GFR Calculator-NKF. The mean values of the eGFR based on cystatin C, calculated by Pediatric GFR Calculator-NKF, significantly differed from the results of the two previous equations (p <0.05).
Values of cystatin C concentration in the blood serum 1.58 6 0.06 mg / l, obtained in patients with CKD III stage, corresponded to an almost identical eGFR on the basis of cystatin C, determined from three different equations. CONCLUSIONS: The data obtained and the results of several studies confirm that in children cystatin C better correlates with the eGFR than serum creatinine. Diagnostically significant values are linked to CKD I-III stages delineation. The informative value of the equations for eGFR based on cystatin C was estimated (F. J. Hoek, M. Zappitelli, Pediatric GFR Calculator-NKF).
FP769 ASSOCIATION OF COMPONENTS OF EXTRACTABLE NUCLEAR ANTIGENS WITH ORGAN INVOLVEMENT IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS
Kalyan Gomes Paediatrics, BSMMU, Dhaka, Bangladesh INTRODUCTION AND AIMS: Extractable nuclear antigen (ENA) profile may predict different organ involvement in systemic lupus erythematosus (SLE), which may help in early diagnosis and initiation of appropriate treatment. This study was designed to find out any significance of ENA profile with organ involvement in childhood SLE patients. METHODS: This cross-sectional study was conducted in the Department of Paediatrics of a tertiary care hospital of a developing country from January 2015 to December 2015. After taking consent from the parents/guardians, patients' clinical and laboratory data were recorded in semi-structured case-record forms. Laboratory investigations included anti-nuclear antibody (ANA), ENA profile, anti-double stranded deoxyribonucleic acid (anti-dsDNA) along with necessary baseline investigations. Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores were also calculated for patients.
RESULTS: Total patients were 50 including 42 females. Mean age at SLE diagnosis and mean disease duration were 12.4662.33 years and 11.0469.46 months respectively. ANA and anti-dsDNA positivity were found in 94% and 86% respectively. The immunofluoresence patterns of ANA were mostly (54%) homogenous. While analyzing the ENA profile it was found that anti-riboneucleoprotein (anti-RNP) (46%) was the most frequent, followed by anti-smooth muscle (anti-Sm) (28%), anti-Sjögren's-syndromerelated antibody A (anti-SSA) (28%) and anti-Sjögren's-syndrome-related antibodyB (anti-SSB) (18%). Homogenous pattern of ANA was associated with anti-RNP (24%) and anti-Sm (14%) autoantibodies. Common presentations included fever (92%), fatigue (82%), arthritis (76%), rash (72%), proteinuria (60%), photosensitivity (54%), mucosal ulceration (54%), alopecia (50%) and hepatosplenomegaly (46%). Only anti-RNP positivity showed significant renal (p¼0.013) and gastrointestinal (p¼0.050) involvement. Renal involvement was also significantly associated with multiple-ENA (p¼0.054) and anti-dsDNA (p¼0.049) positivity. The high disease activity was significantly associated with anti-dsDNA (p¼0.040) positivity. CONCLUSIONS: Components of ENA profile positivity were indicative with organ involvement especially renal and gastrointestinal systems in childhood SLE patients. 
FP770 THE EFFECT OF IN-UTERO EXPOSURE TO TENOFOVIR DISOPROXIL FUMARATE ON THE RENAL FUNCTION OF NEWBORNS OF HIV-POSITIVE MOTHERS

INTRODUCTION AND AIMS:
Combined antiretroviral therapy(c-ART) decreased mother-to-child transmission of HIV by to 1%. However, since the introduction of option B, and subsequently the B þ option in 2012, tenofovir disoproxil fumarate(TDF) has become a major drug in the c-ART regimen used for prevention of mother-to-child transmission. TDF passively diffuses across the placenta and may therefore be potentially toxic to the foetal kidney. Previous studies suggesting renal safety in children exposed in utero are based on serum creatinine and phosphate. We sought to evaluate the effect of in-utero exposure to tenofovir TDF on the renal function of newborns of HIV positive mothers using novel biomarkers of renal function. METHODS: This was a retrospective cohort study including newborns of HIV-positive mothers exposed to TDF in utero and newborns of HIV-negative mothers not exposed to TDF who were born in Yaounde between January 2017 and April 2017. Newborns with asphyxia, renal malformations, early neonatal infections, or preterm, were excluded. All neonates were examined within the first two days of life, then venous blood collected for serum creatinine assay. At the same time, urine samples were collected, centrifuged and stored at -80 C. for subsequent assay of Retinol Binding Protein 4 (RBP-4) and beta-2 microglobulin (b-2M) by Luminex at the Biotechnology Center of the University of Yaounde I . The study was approved by the regional ethics committee. RESULTS: We included 43 neonates exposed to TDF and 39 non-exposed. The average gestational age was 39.47 6 1.12 weeks and comparable in both groups. The mean duration of exposure to TDF was 31 6 10.82 weeks. The median urinary level of b-2M was significantly higher in the exposed compared to the non-exposed group (5.76 vs. 1.97mg / l, p ¼ 0.028). The median urinary level of RBP-4 was higher in TDF-exposed neonates compared to non-exposed subjects without a statistically significant difference (0.75 vs 0.45 mg / l, p ¼ 0.568). Mean serum creatinine levels were also higher in the exposed group but the difference did not attain statistical significance (7.52 vs 7.15 mg / l, p ¼ 0.57). CONCLUSIONS: Exposure to TDF during pregnancy may cause renal dysfunction in the newborn. Follow up studies are needed to evaluate the clinical significance of this findings. 
